Utilidad de la deoxiglucosa marcada con flúor-18 (FDG) en el manejo de los linfomas / Role of 18Fluorine-deoxyglucose (FDG) positron emission tomography in the management of lymphomas
Rev. méd. Chile
;
134(7): 910-919, jul. 2006. ilus, tab
Artículo
en Español
| LILACS
| ID: lil-434594
RESUMO
Positron emission tomography (PET) with fluorine-18 labeled deoxyglucose (FDG) is useful in the management of lymphomas. In this review, some general concepts of this metabolic test are defined. It has an excellent diagnostic yield in Hodgkin disease as well as in most non Hodgkin lymphomas. Staging, restaging residual mass evaluation and the control of therapy are the main indications for FDG-PET. Images with FDG have a high diagnostic and prognostic value, that is superior to anatomical images and conventional staging techniques. They are also helpful for the assessment of tumor activity in abnormal lymph nodes or large masses that have been treated and reduce their size slowly or show an incomplete resolution. Currently, the resolution of dedicated PET equipments is 6 mm and bigger lesions can easily be detected. The main differences and advantages of FDG versus gallium-67 in lymphoma are also discussed, as well as the initial local experience with the technique in lymphoma patients.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Linfoma no Hodgkin
/
Enfermedad de Hodgkin
/
Radiofármacos
/
Tomografía de Emisión de Positrones
Tipo de estudio:
Estudio diagnóstico
/
Estudio pronóstico
Límite:
Adulto
/
Anciano
/
Aged80
/
Femenino
/
Humanos
/
Masculino
Idioma:
Español
Revista:
Rev. méd. Chile
Asunto de la revista:
Medicina
Año:
2006
Tipo del documento:
Artículo
País de afiliación:
Chile
Institución/País de afiliación:
Clínica Santa María/CL
/
Hospital Militar de Santiago/CL
/
Universidad de Chile/CL
Similares
MEDLINE
...
LILACS
LIS